Acetylsalicylic acid Active Not Recruiting Phase 4 Trials for Percutaneous Transluminal Coronary Angioplasty / Coronary Heart Disease (CHD) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT02939872Optimal Duration of Antiplatelet Therapy After Bioresorbable Vascular Scaffold Implantation to Reduce Late Coronary Arterial Thrombotic Events